Parliamentary panel for framing price control regime for COVID medicines medical devices
The panel also recommended exemption of basic customs duty and GST on medicines and medical devices for fighting COVID-19
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DoP
Deadline for proposals under PLI scheme for bulk drugs extended till March-end
The DoP had issued notice on 27th January inviting applications for vacant slots (10 APIs) under PLI scheme for bulk drug with the…
Government earmarks Rs 500 crores for scheme to support pharma clusters and MSMEs
The objectives of the scheme are to strengthen the existing infrastructure facilities to make India a global leader in the pharma…
Centre to mandatorily revise ceiling prices of drugs every five years
The order is with regard to the Indian Drugs Manufacturers Association's (IDMA) views on notification No. S.O. 3249 (E), dated…
DoP takes measures to mandatorily revise ceiling prices of drugs every five years
Amends Para 18(i) of DPCO 2013 as per a notification issued on August 12, 2021
DoP amends Drugs (Prices Control) Order, 2013
In the amendment, DoP provided the proforma for a price list for medical devices, which needs to be submitted
Industry maange more
Recently, the Ministry of Environment, Forest and Climate Change (MoEF) brought an amendment by bringing API and intermediates…
DoP asks NPPA to review, verify Bharat Serum and Vaccine’s request of revising ceiling price…
The company submitted its application expressing that the NPPA has erred in fixing the ceiling price of formulation
DoP submits revised PTUAS scheme document to Expenditure Finance Committee
The revised scheme is likely to roll out from the next financial year